Use of surrogate endpoints in health technology assessment and reimbursement of treatments for the management of chronic kidney disease
Use of surrogate endpoints in health technology assessment and reimbursement of treatments for the management of chronic kidney disease is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Use of surrogate endpoints in health technology assessment and reimbursement of treatments for the management of chronic kidney disease have?
Use of surrogate endpoints in health technology assessment and reimbursement of treatments for the management of chronic kidney disease has 6 citations in the OpenAlex counts ScholarIQ stores.
When was Use of surrogate endpoints in health technology assessment and reimbursement of treatments for the management of chronic kidney disease published?
Use of surrogate endpoints in health technology assessment and reimbursement of treatments for the management of chronic kidney disease has 2025 year in the ScholarIQ index.
What is the open-access status of Use of surrogate endpoints in health technology assessment and reimbursement of treatments for the management of chronic kidney disease?
Use of surrogate endpoints in health technology assessment and reimbursement of treatments for the management of chronic kidney disease has gold oa status in the ScholarIQ index.
What is the DOI of Use of surrogate endpoints in health technology assessment and reimbursement of treatments for the management of chronic kidney disease?
The DOI for Use of surrogate endpoints in health technology assessment and reimbursement of treatments for the management of chronic kidney disease is on the source record.
What is the PMID of Use of surrogate endpoints in health technology assessment and reimbursement of treatments for the management of chronic kidney disease?
The PMID for Use of surrogate endpoints in health technology assessment and reimbursement of treatments for the management of chronic kidney disease is on the source record.
What is the OpenAlex record for Use of surrogate endpoints in health technology assessment and reimbursement of treatments for the management of chronic kidney disease?
The OpenAlex for Use of surrogate endpoints in health technology assessment and reimbursement of treatments for the management of chronic kidney disease is on the source record.